Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 495

1.

Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients.

Rauwel B, Degboé Y, Nigon D, Boyer JF, Abravanel F, Izopet J, Combe B, Ruyssen-Witrand A, Constantin A, Cantagrel A, Davignon JL.

Arthritis Res Ther. 2020 Jan 20;22(1):13. doi: 10.1186/s13075-020-2098-1.

2.

Does HEV-3 subtype play a role in the severity of acute hepatitis E?

Abravanel F, Dimeglio C, Castanier M, Péron JM, Kamar N, Lhomme S, Izopet J.

Liver Int. 2020 Feb;40(2):333-337. doi: 10.1111/liv.14329. Epub 2019 Dec 22.

PMID:
31837187
3.

Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance.

Raymond S, Nicot F, Abravanel F, Minier L, Carcenac R, Lefebvre C, Harter A, Martin-Blondel G, Delobel P, Izopet J.

J Clin Virol. 2020 Jan;122:104229. doi: 10.1016/j.jcv.2019.104229. Epub 2019 Nov 26.

PMID:
31809945
4.

The Prevalence of Hepatitis E in a Patient Cohort Presenting With Addictive Injection Behavior.

Yrondi A, Salles J, Péron JM, Sporer M, Taib S, Gallini A, Noilhan C, Dimeglio C, Entajan F, Crequy M, Izopet J, Schmitt L.

Front Psychiatry. 2019 Nov 12;10:832. doi: 10.3389/fpsyt.2019.00832. eCollection 2019.

5.

Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.

Kamar N, Abravanel F, Behrendt P, Hofmann J, Pageaux GP, Barbet C, Moal V, Couzi L, Horvatits T, De Man RA, Cassuto E, Elsharkawy AM, Riezebos-Brilman A, Scemla A, Hillaire S, Donnelly MC, Radenne S, Sayegh J, Garrouste C, Dumortier J, Glowaki F, Matignon M, Coilly A, Figueres L, Mousson C, Minello A, Dharancy S, Rerolle JP, Lebray P, Etienne I, Perrin P, Choi M, Marion O, Izopet J; Hepatitis E Virus Ribavirin Study Group .

Clin Infect Dis. 2019 Dec 3. pii: ciz953. doi: 10.1093/cid/ciz953. [Epub ahead of print]

PMID:
31793638
6.

Performance of the Xpert HBV Viral Load assay versus the Aptima Quant assay for quantifying hepatitis B virus DNA.

Abravanel F, Lhomme S, Trémeaux P, Migueres M, Harter A, Haslé C, Bruel P, Alric L, Métivier S, Raymond S, Izopet J.

Diagn Microbiol Infect Dis. 2020 Feb;96(2):114946. doi: 10.1016/j.diagmicrobio.2019.114946. Epub 2019 Nov 16.

PMID:
31771903
7.

Hepatitis E virus replication in human intestinal cells.

Marion O, Lhomme S, Nayrac M, Dubois M, Pucelle M, Requena M, Migueres M, Abravanel F, Peron JM, Carrere N, Suc B, Delobel P, Kamar N, Izopet J.

Gut. 2019 Nov 14. pii: gutjnl-2019-319004. doi: 10.1136/gutjnl-2019-319004. [Epub ahead of print]

PMID:
31727684
8.

Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients.

Protin C, Abravanel F, Alric L, Tavitian S, Obéric L, Izopet J, Martin-Blondel G, Ysebaert L.

Open Forum Infect Dis. 2019 Jul 28;6(9):ofz345. doi: 10.1093/ofid/ofz345. eCollection 2019 Sep.

9.

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.

Gordon CE, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, Kamar N, Kasiske BL, Lai CL, Morales JM, Patel PR, Pol S, Silva MO, Balk EM, Earley A, Di M, Cheung M, Jadoul M, Martin P.

Ann Intern Med. 2019 Sep 24. doi: 10.7326/M19-1539. [Epub ahead of print]

PMID:
31546256
10.

Hepatitis E virus infections in Europe.

Izopet J, Tremeaux P, Marion O, Migueres M, Capelli N, Chapuy-Regaud S, Mansuy JM, Abravanel F, Kamar N, Lhomme S.

J Clin Virol. 2019 Nov;120:20-26. doi: 10.1016/j.jcv.2019.09.004. Epub 2019 Sep 8.

PMID:
31536936
11.

THETA: A new genotypic approach for predicting HIV-1 CRF02-AG coreceptor usage.

Dimeglio C, Raymond S, Jeanne N, Reynes C, Carcenac R, Lefebvre C, Cazabat M, Nicot F, Delobel P, Izopet J.

Bioinformatics. 2019 Jul 26. pii: btz585. doi: 10.1093/bioinformatics/btz585. [Epub ahead of print]

PMID:
31350559
12.

Transfusion-Transmitted Hepatitis E Virus Infection in France.

Gallian P, Pouchol E, Djoudi R, Lhomme S, Mouna L, Gross S, Bierling P, Assal A, Kamar N, Mallet V, Roque-Afonso AM, Izopet J, Tiberghien P.

Transfus Med Rev. 2019 Jul;33(3):146-153. doi: 10.1016/j.tmrv.2019.06.001. Epub 2019 Jun 20. Review.

PMID:
31327668
13.

Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.

Lhomme S, DebRoy S, Kamar N, Abravanel F, Metsu D, Marion O, Dimeglio C, Cotler SJ, Izopet J, Dahari H.

Viruses. 2019 Jul 9;11(7). pii: E630. doi: 10.3390/v11070630.

14.

Long-term evolution of transmitted CXCR4-using HIV-1 under effective antiretroviral therapy.

Raymond S, Jeanne N, Nicot F, Lefebvre C, Carcenac R, Minier L, Chiabrando J, Cazabat M, Delobel P, Izopet J.

AIDS. 2019 Nov 1;33(13):1977-1985. doi: 10.1097/QAD.0000000000002295.

PMID:
31259760
15.

Hepatitis E Virus Infections among Patients with Acute Febrile Jaundice in Burkina Faso.

Dimeglio C, Kania D, Mantono JM, Kagoné T, Zida S, Tassembedo S, Dicko A, Tinto B, Yaro S, Hien H, Rouamba J, Bicaba B, Medah I, Meda N, Traoré O, Tuaillon E, Abravanel F, Izopet J.

Viruses. 2019 Jun 14;11(6). pii: E554. doi: 10.3390/v11060554.

16.

Multirecombinant Enterovirus A71 Subgenogroup C1 Isolates Associated with Neurologic Disease, France, 2016-2017.

Ngangas ST, Lukashev A, Jugie G, Ivanova O, Mansuy JM, Mengelle C, Izopet J, L'honneur AS, Rozenberg F, Leyssene D, Hecquet D, Marque-Juillet S, Boutolleau D, Burrel S, Peigue-Lafeuille H, Archimbaud C, Benschop K, Henquell C, Mirand A, Bailly JL.

Emerg Infect Dis. 2019 Jun;25(6):1204-1208. doi: 10.3201/eid2506.181460.

17.

Viral load and clinical manifestations of hepatitis E virus genotype 3 infections.

Lhomme S, Gallian P, Dimeglio C, Assal A, Abravanel F, Tiberghien P, Izopet J.

J Viral Hepat. 2019 Sep;26(9):1139-1142. doi: 10.1111/jvh.13128. Epub 2019 Jun 10.

PMID:
31099059
18.

Screening, diagnosis and risks associated with Hepatitis E virus infection.

Lhomme S, Legrand-Abravanel F, Kamar N, Izopet J.

Expert Rev Anti Infect Ther. 2019 Jun;17(6):403-418. doi: 10.1080/14787210.2019.1613889. Epub 2019 May 13.

PMID:
31082277
19.

Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV Diagnosis.

Sayed IM, Verhoye L, Montpellier C, Abravanel F, Izopet J, Cocquerel L, Meuleman P.

J Infect Dis. 2019 Jul 31;220(5):811-819. doi: 10.1093/infdis/jiz171.

PMID:
31001628
20.

No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents.

Del Bello A, Abravanel F, Alric L, Lavayssiere L, Lhomme S, Bellière J, Izopet J, Kamar N.

Transpl Infect Dis. 2019 Aug;21(4):e13093. doi: 10.1111/tid.13093. Epub 2019 Apr 30.

PMID:
30972874
21.

Peripheral Plasma and Semen Cytokine Response to Zika Virus in Humans.

Mansuy JM, El Costa H, Gouilly J, Mengelle C, Pasquier C, Martin-Blondel G, Izopet J, Jabrane-Ferrat N.

Emerg Infect Dis. 2019 Apr;25(4):823-825. doi: 10.3201/eid2504.171886.

22.

Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection.

Loiseau C, Requena M, Nayrac M, Mavigner M, Cazabat M, Iscache AL, Carrere N, Suc B, Alric L, Izopet J, Delobel P.

J Infect Dis. 2019 Jul 31;220(5):830-840. doi: 10.1093/infdis/jiz123.

PMID:
30880342
23.

[Hepatitis E virus infection].

Marion O, Izopet J, Kamar N.

Rev Prat. 2018 Mar;68(3):286-290. French.

PMID:
30869287
24.

Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection?

Marion O, Lhomme S, Abravanel F, Izopet J, Kamar N.

Transpl Infect Dis. 2019 Jun;21(3):e13065. doi: 10.1111/tid.13065. Epub 2019 Mar 22. No abstract available.

PMID:
30860299
25.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.

Assoumou L, Bocket L, Pallier C, Grude M, Ait-Namane R, Izopet J, Raymond S, Charpentier C, Visseaux B, Wirden M, Trabaud MA, Le Guillou-Guillemette H, Allaoui C, Henquell C, Krivine A, Dos Santos G, Delamare C, Bouvier-Alias M, Montes B, Ferre V, De Monte A, Signori-Schmuck A, Maillard A, Morand-Joubert L, Tumiotto C, Fafi-Kremer S, Amiel C, Barin F, Marque-Juillet S, Courdavault L, Vallet S, Beby-Defaux A, de Rougemont A, Fenaux H, Avettand-Fenoel V, Allardet-Servent A, Plantier JC, Peytavin G, Calvez V, Chaix ML, Descamps D; ANRS AC-43 Resistance Study Group.

J Antimicrob Chemother. 2019 May 1;74(5):1417-1424. doi: 10.1093/jac/dkz011.

PMID:
30753724
26.

HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy.

Guerveno C, Raymond S, Metsu D, Gandia P, Izopet J, Martin-Blondel G, Delobel P.

AIDS. 2019 Mar 1;33(3):593-594. doi: 10.1097/QAD.0000000000002089. No abstract available.

PMID:
30702524
27.

Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection.

Marion O, Abravanel F, Izopet J, Kamar N.

Transpl Infect Dis. 2019 Apr;21(2):e13050. doi: 10.1111/tid.13050. Epub 2019 Feb 4. No abstract available.

PMID:
30663838
28.

Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patients.

Marion O, Capelli N, Lhomme S, Dubois M, Pucelle M, Abravanel F, Kamar N, Izopet J.

J Infect. 2019 Mar;78(3):232-240. doi: 10.1016/j.jinf.2019.01.004. Epub 2019 Jan 17.

PMID:
30659856
29.

Performance characteristics of the VIDAS® ANTI-HEV IgM and IgG assays.

Abravanel F, Goutagny N, Joffray R, Eichenlaub E, Baron S, Aversenq A, Bourg S, Mercier L, Larue Triolet A, Poirault D, Loubet M, Daniel S, Luciani F, Pothion C, Tourneur C, Dugua JM, Lhomme S, Izopet J.

J Clin Virol. 2019 Mar;112:10-14. doi: 10.1016/j.jcv.2019.01.005. Epub 2019 Jan 11.

PMID:
30658273
30.

Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients.

Marion O, Lhomme S, Del Bello A, Abravanel F, Esposito L, Hébral AL, Lavayssière L, Cointault O, Ribes D, Izopet J, Kamar N.

J Hepatol. 2019 Jan;70(1):206-209. doi: 10.1016/j.jhep.2018.09.011. Epub 2018 Oct 24. No abstract available.

PMID:
30563687
31.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen.

Dimeglio C, Raymond S, Nicot F, Jeanne N, Carcenac R, Lefebvre C, Izopet J; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group .

J Antimicrob Chemother. 2019 Mar 1;74(3):718-721. doi: 10.1093/jac/dky495.

PMID:
30535228
32.

Hepatitis E prevalence in French Polynesian blood donors.

Dimeglio C, Beau F, Broult J, Gouy P, Izopet J, Lastère S, Abravanel F.

PLoS One. 2018 Dec 7;13(12):e0208934. doi: 10.1371/journal.pone.0208934. eCollection 2018.

33.

CCR5 structural plasticity shapes HIV-1 phenotypic properties.

Colin P, Zhou Z, Staropoli I, Garcia-Perez J, Gasser R, Armani-Tourret M, Benureau Y, Gonzalez N, Jin J, Connell BJ, Raymond S, Delobel P, Izopet J, Lortat-Jacob H, Alcami J, Arenzana-Seisdedos F, Brelot A, Lagane B.

PLoS Pathog. 2018 Dec 6;14(12):e1007432. doi: 10.1371/journal.ppat.1007432. eCollection 2018 Dec.

34.

Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.

Capelli N, Marion O, Dubois M, Allart S, Bertrand-Michel J, Lhomme S, Abravanel F, Izopet J, Chapuy-Regaud S.

J Virol. 2019 Feb 5;93(4). pii: e01207-18. doi: 10.1128/JVI.01207-18. Print 2019 Feb 15.

35.

Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface.

Gouilly J, Chen Q, Siewiera J, Cartron G, Levy C, Dubois M, Al-Daccak R, Izopet J, Jabrane-Ferrat N, El Costa H.

Nat Commun. 2018 Nov 12;9(1):4748. doi: 10.1038/s41467-018-07200-2.

36.

Performance of a commercial assay for detecting and quantifying HEV RNA in faeces.

Abravanel F, Lacipière A, Lhomme S, Dubois M, Minier L, Peron JM, Alric L, Kamar N, Izopet J.

J Clin Virol. 2018 Dec;109:1-5. doi: 10.1016/j.jcv.2018.10.003. Epub 2018 Oct 10.

PMID:
30336371
37.

Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.

Jadoul M, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, Kamar N, Kasiske BL, Lai CL, Morales JM, Patel PR, Pol S, Silva MO, Balk EM, Gordon CE, Earley A, Di M, Martin P.

Kidney Int. 2018 Oct;94(4):663-673. doi: 10.1016/j.kint.2018.06.011.

38.

Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing.

Raymond S, Delaugerre C, Nicot F, Assoumou L, Lancar R, Beniguel L, Izopet J; ANRS 146 OPTIMAL study group.

AIDS. 2018 Oct 23;32(16):2429-2431. doi: 10.1097/QAD.0000000000001976.

PMID:
30102658
39.

Detection of Zika, dengue and chikungunya viruses using single-reaction multiplex real-time RT-PCR.

Mansuy JM, Lhomme S, Cazabat M, Pasquier C, Martin-Blondel G, Izopet J.

Diagn Microbiol Infect Dis. 2018 Dec;92(4):284-287. doi: 10.1016/j.diagmicrobio.2018.06.019. Epub 2018 Jun 28.

PMID:
30029808
40.

Acute hepatitis E in French patients and neurological manifestations.

Abravanel F, Pique J, Couturier E, Nicot F, Dimeglio C, Lhomme S, Chiabrando J, Saune K, Péron JM, Kamar N, Evrard S, de Valk H, Cintas P, Izopet J; HEV study group.

J Infect. 2018 Sep;77(3):220-226. doi: 10.1016/j.jinf.2018.06.007. Epub 2018 Jul 10.

PMID:
29966614
41.

A fully automated system using transcription-mediated amplification for the molecular diagnosis of hepatitis E virus in human blood and faeces.

Abravanel F, Lhomme S, Chapuy-Regaud S, Mansuy JM, Boineau J, Sauné K, Izopet J.

J Clin Virol. 2018 Aug;105:109-111. doi: 10.1016/j.jcv.2018.06.013. Epub 2018 Jun 22.

PMID:
29957544
42.

Diversity of hepatitis E virus genotype 3.

Nicot F, Jeanne N, Roulet A, Lefebvre C, Carcenac R, Manno M, Dubois M, Kamar N, Lhomme S, Abravanel F, Izopet J.

Rev Med Virol. 2018 Sep;28(5):e1987. doi: 10.1002/rmv.1987. Epub 2018 Jun 25.

PMID:
29939461
43.

Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients.

Marion O, Abravanel F, Del Bello A, Esposito L, Lhomme S, Puissant-Lubrano B, Alric L, Faguer S, Izopet J, Kamar N.

Liver Int. 2018 Dec;38(12):2178-2189. doi: 10.1111/liv.13894. Epub 2018 Jun 14.

PMID:
29845733
44.

Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.

Grellier J, Hirsch HH, Mengelle C, Esposito L, Hebral AL, Bellière J, Weissbach F, Izopet J, Del Bello A, Kamar N.

Transpl Infect Dis. 2018 Aug;20(4):e12917. doi: 10.1111/tid.12917. Epub 2018 Jun 11.

PMID:
29800505
45.

Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.

Lambert-Niclot S, Grude M, Meynard JL, Marcelin AG, Valantin MA, Flandre P, Izopet J, Moinot L, Bouteloup V, Calvez V, Katlama C, Girard PM, Morand-Joubert L.

Clin Infect Dis. 2018 Nov 28;67(12):1883-1889. doi: 10.1093/cid/ciy382.

46.

Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.

Nicot F, Jeanne N, Raymond S, Delfour O, Carcenac R, Lefebvre C, Sauné K, Delobel P, Izopet J.

J Med Virol. 2018 Sep;90(9):1486-1492. doi: 10.1002/jmv.25224. Epub 2018 May 25.

PMID:
29750364
47.

Transmission of Hepatitis E Virus With Plasma Exchange in Kidney Transplant Recipients: A Retrospective Cohort Study.

Mallet V, Sberro-Soussan R, Roque-Afonso AM, Vallet-Pichard A, Deau B, Portal A, Chaix ML, Hauser L, Beylouné A, Mercadier A, Izopet J, Legendre C, Pol S.

Transplantation. 2018 Aug;102(8):1351-1357. doi: 10.1097/TP.0000000000002185.

PMID:
29561324
48.

Transmission and Epidemiology of Hepatitis E Virus Genotype 3 and 4 Infections.

Dalton HR, Izopet J.

Cold Spring Harb Perspect Med. 2018 Nov 1;8(11). pii: a032144. doi: 10.1101/cshperspect.a032144. Review.

PMID:
29530946
49.

Monitoring human enteric viruses in wastewater and relevance to infections encountered in the clinical setting: a one-year experiment in central France, 2014 to 2015.

Bisseux M, Colombet J, Mirand A, Roque-Afonso AM, Abravanel F, Izopet J, Archimbaud C, Peigue-Lafeuille H, Debroas D, Bailly JL, Henquell C.

Euro Surveill. 2018 Feb;23(7). doi: 10.2807/1560-7917.ES.2018.23.7.17-00237.

50.

HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.

Raymond S, Nicot F, Carcenac R, Lefebvre C, Jeanne N, Saune K, Delobel P, Izopet J.

J Antimicrob Chemother. 2018 May 1;73(5):1152-1157. doi: 10.1093/jac/dky003.

PMID:
29444253

Supplemental Content

Loading ...
Support Center